JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01683-06v1
81/4/1727    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyamoto, H.
Right arrow Articles by Matsuura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyamoto, H.
Right arrow Articles by Matsuura, Y.
Journal of Virology, February 2007, p. 1727-1735, Vol. 81, No. 4
0022-538X/07/$08.00+0     doi:10.1128/JVI.01683-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Involvement of the PA28{gamma}-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein{triangledown}

Hironobu Miyamoto,1 Kohji Moriishi,1 Kyoji Moriya,2 Shigeo Murata,3 Keiji Tanaka,3 Tetsuro Suzuki,4 Tatsuo Miyamura,4 Kazuhiko Koike,2 and Yoshiharu Matsuura1*

Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka,1 Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Tokyo,2 Department of Molecular Oncology, Tokyo Metropolitan Institute of Medical Science, Tokyo,3 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan4

Received 4 August 2006/ Accepted 16 November 2006

The hepatitis C virus (HCV) core protein is a component of nucleocapsids and a pathogenic factor for hepatitis C. Several epidemiological and experimental studies have suggested that HCV infection is associated with insulin resistance, leading to type 2 diabetes. We have previously reported that HCV core gene-transgenic (PA28{gamma}+/+CoreTg) mice develop marked insulin resistance and that the HCV core protein is degraded in the nucleus through a PA28{gamma}-dependent pathway. In this study, we examined whether PA28{gamma} is required for HCV core-induced insulin resistance in vivo. HCV core gene-transgenic mice lacking the PA28{gamma} gene (PA28{gamma}–/–CoreTg) were prepared by mating of PA28{gamma}+/+CoreTg with PA28{gamma}-knockout mice. Although there was no significant difference in the glucose tolerance test results among the mice, the insulin sensitivity in PA28{gamma}–/–CoreTg mice was recovered to a normal level in the insulin tolerance test. Tyrosine phosphorylation of insulin receptor substrate 1 (IRS1), production of IRS2, and phosphorylation of Akt were suppressed in the livers of PA28{gamma}+/+CoreTg mice in response to insulin stimulation, whereas they were restored in the livers of PA28{gamma}–/–CoreTg mice. Furthermore, activation of the tumor necrosis factor alpha promoter in human liver cell lines or mice by the HCV core protein was suppressed by the knockdown or knockout of the PA28{gamma} gene. These results suggest that the HCV core protein suppresses insulin signaling through a PA28{gamma}-dependent pathway.


* Corresponding author. Mailing address: Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan. Phone: 81-6-6879-8340. Fax: 81-6-6879-8269. E-mail: matsuura{at}biken.osaka-u.ac.jp.

{triangledown} Published ahead of print on 29 November 2006.


Journal of Virology, February 2007, p. 1727-1735, Vol. 81, No. 4
0022-538X/07/$08.00+0     doi:10.1128/JVI.01683-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.